2013
DOI: 10.4149/gpb_2013055
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of exaggerated neuronal oscillations by oxytocin in a rat model of Parkinson’s disease

Abstract: Abstract.Increased oscillatory activity has been demonstrated in the basal ganglia of Parkinson's disease (PD) patients. The aim of the present study was to evaluate the effects of oxytocin (OT) on local field potentials (LFPs) in a rotenone-induced rat model of PD. Adult male Sprague-Dawley rats were unilaterally injected with rotenone (3 µg/µl in DMSO) into the left substantia nigra pars compacta whereas vehicle group was received only DMSO. PD-developed rats were then administered either OT (160 µg/kg/day, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 49 publications
0
1
0
1
Order By: Relevance
“…Consistently, a reduction of the number of OT-immunoreactive neurons in the hypothalamus of PD patients [97], and the ability of OT to influence locomotor activity at the level of the substantia nigra [98], possibly suggest that a decrease of OT levels in the brain areas receiving oxytocinergic projections may play a role in the motor disabilities in PD patients [98]. Accordingly, OT was reported to possess neuroprotective effects on rotenone-induced PD in rats [99,100] or in MPTP-treated mice [101]. In fact, OT could allow the astrocytic D2 receptor's activation by low extracellular levels of dopamine and could rescue the reduced activation of the D2 receptors (by a defective dopaminergic transmission in PD).…”
Section: Potential Relevance Of Striatal Astrocytic D2-otr Heteromersmentioning
confidence: 89%
“…Consistently, a reduction of the number of OT-immunoreactive neurons in the hypothalamus of PD patients [97], and the ability of OT to influence locomotor activity at the level of the substantia nigra [98], possibly suggest that a decrease of OT levels in the brain areas receiving oxytocinergic projections may play a role in the motor disabilities in PD patients [98]. Accordingly, OT was reported to possess neuroprotective effects on rotenone-induced PD in rats [99,100] or in MPTP-treated mice [101]. In fact, OT could allow the astrocytic D2 receptor's activation by low extracellular levels of dopamine and could rescue the reduced activation of the D2 receptors (by a defective dopaminergic transmission in PD).…”
Section: Potential Relevance Of Striatal Astrocytic D2-otr Heteromersmentioning
confidence: 89%
“…[21] Erba ve ark. [22,23] rotenon ile oluturulan Parkinson modelinde oksitosinin sinir koruyucu etkilerini ve Parkinsonda artan striatal elektriksel aktivite artıını azalttı¤ını göstermilerdir. Erba ve ark.…”
unclassified